XML 37 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Loss Per Share (Tables)
 9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Diluted Earnings Per Share
The following tables reconcile the components of the numerator and denominator included in the calculations of diluted net loss per share:
 
Three Months Ended September 30,
 
2017
 
2016
Numerator
 
 
 
Net loss attributed to Inovio Pharmaceuticals, Inc
$
(34,134,570
)
 
$
(20,759,338
)
Adjustment for decrease in fair value of warrant liability
(423,296
)
 
(2,841
)
Numerator for use in diluted net loss per share
$
(34,557,866
)
 
$
(20,762,179
)
 
 
 
 
Denominator
 
 
 
Weighted average number of common shares outstanding
86,952,024

 
73,602,834

Effect of dilutive potential common shares
138,659

 
186,174

Denominator for use in diluted net loss per share
87,090,683

 
73,789,008

 
 
 
 
Net loss per share, diluted:
$
(0.40
)
 
$
(0.28
)
 
Nine Months Ended September 30,
 
2017
 
2016
Numerator
 
 
 
Net loss attributed to Inovio Pharmaceuticals, Inc
$
(66,699,593
)
 
$
(47,506,869
)
Adjustment for decrease in fair value of warrant liability
(227,273
)
 
—

Numerator for use in diluted net loss per share
$
(66,926,866
)
 
$
(47,506,869
)
 
 
 
 
Denominator
 
 
 
Weighted average number of common shares outstanding
78,894,881

 
72,932,199

Effect of dilutive potential common shares
148,599

 
—

Denominator for use in diluted net loss per share
79,043,480

 
72,932,199

 
 
 
 
Net loss per share, diluted:
$
(0.85
)
 
$
(0.65
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes potential shares of common stock that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the three months ended September 30, 2017 and 2016:
 
 
Common Stock Equivalents
2017
 
2016
Options to purchase common stock
7,811,387

 
6,747,961

Restricted stock units
1,324,410

 
771,335

Convertible preferred stock
8,456

 
8,456

Total
9,144,253

 
7,527,752